Astrazeneca Vaccine For Covid
- All
- News
- Videos
-
AstraZeneca Drops Covid Vaccine Weeks After Rare Side Effect Report
AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine, days after it was reported that the British pharmaceutical company admitted that the jab can cause rare side effects.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
High Hopes For Nasal Covid Vaccines Despite "Disappointing" Trial
Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
-
AstraZeneca Claims Positive Medicine Trial For "Severe" Covid
A treatment for people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday.
-
European Union Drugs Regulator Approves AstraZeneca Jab As Covid Booster
AstraZeneca's Covid jab has won approval for use as a booster or third jab in the European Union, the British drugs giant confirmed Monday.
-
Taiwan Okays Locally Made Covid Vaccine For Emergency Use
Taiwan's government on Monday said it had granted emergency-use approval to a coronavirus vaccine made locally by Medigen, with experts saying early data suggested it was similarly effective to AstraZeneca's jabs.
-
Thailand Says AstraZeneca Asked To Delay Delivery Of 61 Million Vaccine Doses
AstraZeneca has asked Thailand to extend the timeline for the delivery of 61 million doses of its COVID-19 vaccine by five months, a deputy minister said on Thursday, a move likely to disrupt further the country's sluggish vaccine rollout.
-
Australia Restricts AstraZeneca Vaccine For All Under 60 Due to Clotting Concerns
Australia recommended that AstraZeneca's Covid-19 jab should not be given to people under 60 on Thursday, a fresh blow to the country's glacial vaccine rollout.
-
What Top European Agency Official Said On AstraZeneca Use Amid Concerns
A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published Sunday.
-
Behind-The-Scenes Of PM Modi's Call With Joe Biden
The U.S. announced Monday it would share its entire supply of AstraZeneca Plc's Covid-19 vaccine with other countries and readied an aid package for India, as President Joe Biden pivots to ramp up U.S. pandemic assistance to the rest of the world.
-
Malaysia Says AstraZeneca Vaccine Safe, Will Be Used For People Over 60
Malaysian health authorities on Monday said the vaccine developed by AstraZeneca is safe for use, three days after the Southeast Asian nation received its first batch of the shots bought through the global COVAX facility.
-
"It Is Clarified That...": On Vaccine Price Criticism, Centre's Tweet
Facing criticism over a new vaccine policy that could have people paying far more for a Covid shot, the government today put out a clarification. It said that vaccines procured by the central government would be provided free to states.
-
Rs 3,000 Crore Boost For Serum Institute Amid Vaccine Shortage: Report
India is set to accept the Serum Institute of India's (SII) request for a 30 billion rupees ($400 million) grant to boost its capacity to make the AstraZeneca COVID-19 vaccine, a government source with knowledge of the matter told Reuters.
-
Angela Merkel Receives AstraZeneca Covid Vaccine
Chancellor Angela Merkel on Friday received her first dose of AstraZeneca's Covid-19 vaccine, more than two weeks after German authorities recommended use of the jab only for people aged 60 and over.
-
AstraZeneca Drops Covid Vaccine Weeks After Rare Side Effect Report
AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine, days after it was reported that the British pharmaceutical company admitted that the jab can cause rare side effects.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
High Hopes For Nasal Covid Vaccines Despite "Disappointing" Trial
Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
-
AstraZeneca Nasal Spray Vaccine For Covid Fizzles In Small, Early Trial
AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.
-
AstraZeneca Claims Positive Medicine Trial For "Severe" Covid
A treatment for people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday.
-
European Union Drugs Regulator Approves AstraZeneca Jab As Covid Booster
AstraZeneca's Covid jab has won approval for use as a booster or third jab in the European Union, the British drugs giant confirmed Monday.
-
Taiwan Okays Locally Made Covid Vaccine For Emergency Use
Taiwan's government on Monday said it had granted emergency-use approval to a coronavirus vaccine made locally by Medigen, with experts saying early data suggested it was similarly effective to AstraZeneca's jabs.
-
Thailand Says AstraZeneca Asked To Delay Delivery Of 61 Million Vaccine Doses
AstraZeneca has asked Thailand to extend the timeline for the delivery of 61 million doses of its COVID-19 vaccine by five months, a deputy minister said on Thursday, a move likely to disrupt further the country's sluggish vaccine rollout.
-
Australia Restricts AstraZeneca Vaccine For All Under 60 Due to Clotting Concerns
Australia recommended that AstraZeneca's Covid-19 jab should not be given to people under 60 on Thursday, a fresh blow to the country's glacial vaccine rollout.
-
What Top European Agency Official Said On AstraZeneca Use Amid Concerns
A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published Sunday.
-
Behind-The-Scenes Of PM Modi's Call With Joe Biden
The U.S. announced Monday it would share its entire supply of AstraZeneca Plc's Covid-19 vaccine with other countries and readied an aid package for India, as President Joe Biden pivots to ramp up U.S. pandemic assistance to the rest of the world.
-
Malaysia Says AstraZeneca Vaccine Safe, Will Be Used For People Over 60
Malaysian health authorities on Monday said the vaccine developed by AstraZeneca is safe for use, three days after the Southeast Asian nation received its first batch of the shots bought through the global COVAX facility.
-
"It Is Clarified That...": On Vaccine Price Criticism, Centre's Tweet
Facing criticism over a new vaccine policy that could have people paying far more for a Covid shot, the government today put out a clarification. It said that vaccines procured by the central government would be provided free to states.
-
Rs 3,000 Crore Boost For Serum Institute Amid Vaccine Shortage: Report
India is set to accept the Serum Institute of India's (SII) request for a 30 billion rupees ($400 million) grant to boost its capacity to make the AstraZeneca COVID-19 vaccine, a government source with knowledge of the matter told Reuters.
-
Angela Merkel Receives AstraZeneca Covid Vaccine
Chancellor Angela Merkel on Friday received her first dose of AstraZeneca's Covid-19 vaccine, more than two weeks after German authorities recommended use of the jab only for people aged 60 and over.
